Home › Funds › Mayar Capital Ltd. › SOLV
Mayar Capital Ltd. position in SOLV
SOLVENTUM CORP · Health Care
Mayar Capital Ltd. reported holding 91,490 shares of SOLV (SOLVENTUM CORP) in its Q3 2026 13F filing — a position valued at US$8.1M, representing 10.24% of its reported portfolio and ranking #3 among its reported holdings. Mayar Capital Ltd. has disclosed SOLV holdings in 10 of the last 10 reported quarters, going back to Q2 2024.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How Mayar Capital Ltd.'s SOLV position evolved
Mayar Capital Ltd. first disclosed a stake in SOLV in Q2 2024 at 11,251 shares (US$595K). The position peaked in Q4 2025 at 106,590 shares, worth US$8.4M. Across 10 filings, Mayar Capital Ltd. increased the stake 3 time(s), trimmed it 3 time(s) and left it unchanged 3 time(s). The most recent filing (Q3 2026) shows 91,490 shares valued at US$8.1M — a reduction of -7,700 shares quarter over quarter.. Notable position changes include a 187% increase in Q4 2024 (shares rose 15% over the following quarter), a 187% increase in Q1 2025 (shares were roughly flat over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2024 | 11.25K | $594.95K | New |
| Q3 2024 | 10.55K | $735.62K | Reduce |
| Q4 2024 | 30.29K | $2.00M | Add |
| Q1 2025 | 86.99K | $6.61M | Add |
| Q2 2025 | 106.59K | $8.08M | Add |
| Q3 2025 | 106.59K | $7.78M | Hold |
| Q4 2025 | 106.59K | $8.45M | Hold |
| Q1 2026 | 106.59K | $6.96M | Hold |
| Q2 2026 | 99.19K | $7.65M | Reduce |
| Q3 2026 | 91.49K | $8.06M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About SOLV and 13F data
SOLV (SOLVENTUM CORP) is a Health Care company. 41 other funds we track also report a position in SOLV — the largest reported positions include Independent Franchise Partners LLP (US$1.38B), TRIAN FUND MANAGEMENT, L.P. (US$635.5M), DAVIS SELECTED ADVISERS (US$565.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding SOLV
- Independent Franchise Partners LLP 15.67M sh · $1.38B · Q3 2026
- TRIAN FUND MANAGEMENT, L.P. 8.24M sh · $635.47M · Q2 2026
- DAVIS SELECTED ADVISERS 6.41M sh · $565.42M · Q3 2026
- Diamond Hill Capital Management, LLC (Investment Advisor) 1.58M sh · $139.38M · Q3 2026
- Madison Avenue Partners, LP 1.74M sh · $134.34M · Q2 2026
- EQUITY INVESTMENT CORP 867.55K sh · $76.47M · Q3 2026
- ANCHOR CAPITAL ADVISORS LLC 533.38K sh · $47.02M · Q3 2026
More on Mayar Capital Ltd.
FAQ
How long has Mayar Capital Ltd. held SOLV?
Mayar Capital Ltd. has disclosed SOLV holdings in 10 of the last 10 reported quarters, going back to Q2 2024.
What is Mayar Capital Ltd.'s current position in SOLV?
As of Q3 2026, Mayar Capital Ltd. holds 91.49K shares of SOLV (SOLVENTUM CORP), valued at $8.06M, representing 10.24% of its reported portfolio and ranking #3.
Has Mayar Capital Ltd. been buying or selling SOLV?
In the latest 13F filing (Q3 2026), Mayar Capital Ltd. reduced its position in SOLV. The position peaked in Q4 2025 at 106.59K shares.
Which other funds hold SOLV?
Other major institutional holders of SOLV include Independent Franchise Partners LLP, TRIAN FUND MANAGEMENT, L.P., DAVIS SELECTED ADVISERS, among 41 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.